Cerberus Research LabsAmerican-run from Asia / US combat veteran owned and operated
Retatrutide is a triple receptor agonist peptide targeting the GIP, GLP-1, and glucagon receptors. It is studied in metabolic and energy-expenditure research models for its multi-receptor activity, and is supplied strictly as a research-use-only catalog material.
Research Use Only. No clinical, diagnostic, human, or veterinary use.
Retatrutide is a triple receptor agonist peptide targeting the GIP, GLP-1, and glucagon receptors. It is studied in metabolic and energy-expenditure research models for its multi-receptor activity, and is supplied strictly as a research-use-only catalog material. Any discussion of future applications is hypothetical and should not be interpreted as human or veterinary use guidance.
Research discussion focuses on pathway signaling and assay behavior in controlled laboratory models, not human outcomes or dosing.
Current literature and supplier documentation are reviewed in the context of compound identity, lot consistency, assay suitability, and controlled research workflow design.
Any future application discussion is hypothetical, non-promotional, and not clinical guidance. This listing is restricted to laboratory research-use-only review.
Reference placeholders can be added after legal and scientific review. Do not treat this catalog page as medical or regulatory advice.
Our free peptide reconstitution calculator converts vial mass and BAC water volume into concentration, volume per draw, and U-100 syringe units. It is arithmetic for laboratory preparation only — it is not dosing guidance, and it says nothing about how Retatrutide should be used.
The certificate of analysis for the lot supplied is published below — you do not have to ask for it. Open COA image
Research-use-only supply questions. Nothing here is dosing, protocol, or usage guidance.
Retatrutide is a triple receptor agonist that targets the GIP, GLP-1, and glucagon receptors. In published preclinical and clinical literature it is examined in metabolic and energy-expenditure research models for its multi-receptor activity. Cerberus supplies it as a research-use-only catalog material for laboratory study.
Yes. Every Retatrutide lot is supplied with certificate-of-analysis documentation available on request, and the COA image for the current lot is linked in the Documentation Status section on this page. Lot documentation can be requested before an order is placed.
Retatrutide ships to the United States and 20+ countries including Canada, the United Kingdom, Australia, Ireland, the Philippines, and South Africa. Checkout is processed in USD through Stripe; some destinations may be unavailable because of carrier suspension or local import restrictions.
Orders are packed discreetly with secure protective packaging for laboratory transport. Tracking is provided once the order ships, and shipping questions are answered directly by U.S. veteran-run support.
Yes. Retatrutide is supplied strictly as a research-use-only catalog material. It is not for human or veterinary use, and not for clinical or diagnostic application. Purchasers confirm research-use-only intent at checkout.
RUO
Tirzepatide is being researched for its role in GLP-1 and GIP signaling pathways within metabolic, appetite-signaling, and glucose-regulation research models.
RUO
Semaglutide is being researched for its role in GLP-1 signaling, metabolic regulation, appetite-signaling models, and glucose-related research pathways.
RUO
Cagrilintide is being researched within metabolic research, appetite signaling, glucose regulation as a research-use-only catalog material for qualified laboratory and analytical workflows.
